Pituitary adenomas that caused Cushing's disease or Nelson's syndrome are not responsive to ovine corticotropin-releasing factor in vitro. 1983

T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling

The response of pituitary adenomas obtained surgically from patients with Cushing's disease of Nelson's syndrome to synthetic ovine corticotropin-releasing factor (CRF), vasopressins, somatostatin-28, dexamethasone, 3-isobutylmethylxanthine or high [K+] was examined in vitro by measuring the amount of pro-opiomelanocortin (POMC)-derived peptides secreted into the culture medium. CRF did not stimulate the secretion of adrenocorticotropin-, beta-endorphin-, or gamma 3-melanotropin-like peptides from the pituitary adenomas at concentrations ranging from 1 x 10(-13) M to 1 x 10(-7) M whereas vasopressins, 3-isobutyrl-methylxanthine and high [K+] increased, while somatostatin-28 and dexamethasone suppressed, the secretion of these POMC-derived peptides. These findings suggest that either the pituitary ACTH-producing tumors have lost their receptors to CRF or their post-receptor mechanism to CRF is not functional.

UI MeSH Term Description Entries
D008297 Male Males
D009074 Melanocyte-Stimulating Hormones Peptides with the ability to stimulate pigmented cells MELANOCYTES in mammals and MELANOPHORES in lower vertebrates. By stimulating the synthesis and distribution of MELANIN in these pigmented cells, they increase coloration of skin and other tissue. MSHs, derived from pro-opiomelanocortin (POMC), are produced by MELANOTROPHS in the INTERMEDIATE LOBE OF PITUITARY; CORTICOTROPHS in the ANTERIOR LOBE OF PITUITARY, and the hypothalamic neurons in the ARCUATE NUCLEUS OF HYPOTHALAMUS. MSH,Melanocyte Stimulating Hormone,Melanocyte-Stimulating Hormone,Melanophore Stimulating Hormone,Melanotropin,MSH (Melanocyte-Stimulating Hormones),Melanophore-Stimulating Hormone,Hormone, Melanocyte Stimulating,Hormone, Melanocyte-Stimulating,Hormone, Melanophore Stimulating,Melanocyte Stimulating Hormones,Stimulating Hormone, Melanocyte,Stimulating Hormone, Melanophore
D009347 Nelson Syndrome A syndrome characterized by HYPERPIGMENTATION, enlarging pituitary mass, visual defects secondary to compression of the OPTIC CHIASM, and elevated serum ACTH. It is caused by the expansion of an underlying ACTH-SECRETING PITUITARY ADENOMA that grows in the absence of feedback inhibition by adrenal CORTICOSTEROIDS, usually after ADRENALECTOMY.
D010911 Pituitary Neoplasms Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA. Pituitary Cancer,Cancer of Pituitary,Cancer of the Pituitary,Pituitary Adenoma,Pituitary Carcinoma,Pituitary Tumors,Adenoma, Pituitary,Adenomas, Pituitary,Cancer, Pituitary,Cancers, Pituitary,Carcinoma, Pituitary,Carcinomas, Pituitary,Neoplasm, Pituitary,Neoplasms, Pituitary,Pituitary Adenomas,Pituitary Cancers,Pituitary Carcinomas,Pituitary Neoplasm,Pituitary Tumor,Tumor, Pituitary,Tumors, Pituitary
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003346 Corticotropin-Releasing Hormone A peptide of about 41 amino acids that stimulates the release of ADRENOCORTICOTROPIC HORMONE. CRH is synthesized by neurons in the PARAVENTRICULAR NUCLEUS of the HYPOTHALAMUS. After being released into the pituitary portal circulation, CRH stimulates the release of ACTH from the PITUITARY GLAND. CRH can also be synthesized in other tissues, such as PLACENTA; ADRENAL MEDULLA; and TESTIS. ACTH-Releasing Hormone,CRF-41,Corticotropin-Releasing Factor,Corticotropin-Releasing Hormone-41,ACTH-Releasing Factor,CRF (ACTH),Corticoliberin,Corticotropin-Releasing Factor-41,ACTH Releasing Factor,ACTH Releasing Hormone,Corticotropin Releasing Factor,Corticotropin Releasing Factor 41,Corticotropin Releasing Hormone,Corticotropin Releasing Hormone 41
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004723 Endorphins One of the three major groups of endogenous opioid peptides. They are large peptides derived from the PRO-OPIOMELANOCORTIN precursor. The known members of this group are alpha-, beta-, and gamma-endorphin. The term endorphin is also sometimes used to refer to all opioid peptides, but the narrower sense is used here; OPIOID PEPTIDES is used for the broader group. Endorphin
D005260 Female Females

Related Publications

T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
November 1982, The Journal of clinical endocrinology and metabolism,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
January 1971, Progress in atomic medicine,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
June 1986, Experimental and clinical endocrinology,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
September 1992, American journal of diseases of children (1960),
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
September 1983, The Journal of clinical endocrinology and metabolism,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
March 1985, The Journal of clinical endocrinology and metabolism,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
November 1990, Endocrinology,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
March 1993, The Journal of pathology,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
December 1990, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology,
T Shibasaki, and M Nakahara, and K Shizume, and Y Kiyosawa, and T Suda, and H Demura, and A Kuwayama, and N Kageyama, and R Benoit, and N Ling
January 1980, Clinical neurosurgery,
Copied contents to your clipboard!